Target intelligence / Profile preview

U6 small nuclear RNA 18 pseudogene (RNU6-18P)

Target: RNU6-18P
Molecular classification: Other (pseudogene; non-coding RNA)

Overview

RNU6-18P is a pseudogene derived from the U6 small nuclear RNA gene family. The U6 snRNAs are integral to the spliceosome complex, which catalyzes intron removal during pre-mRNA processing in eukaryotes[1][3]. The pseudogene version (RNU6-18P) is a genomic copy that typically does not produce functional RNA and lacks direct biological or therapeutic relevance. Functional U6 snRNAs are highly conserved and essential for the splicing reaction, but pseudogenes such as RNU6-18P are considered biologically inert—having no established function, disease association, or direct interaction with drugs[3].

Other names: RNU6-18PRNU6-18RNA, U6 small nuclear 18, pseudogene

Beyond the preview

Go deeper on U6 small nuclear RNA 18 pseudogene (RNU6-18P).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Explore the programs pursuing this target and their development progress.

Drug candidates
Developers
Development stage

Clinical trials

Follow the clinical studies evaluating therapies directed at this target.

Trial design
Status
Readouts

Competitive landscape

Compare approaches across drug candidates, modalities, and indications.

Programs
Modalities
Indications

Literature & evidence

Investigate the research and source evidence behind target biology and development.

Publications
Sources
Analysis

Patents

Explore patent activity around therapies and technologies addressing this target.

Patents
Assignees
Technologies

Research & analysis

Connect target biology, drug development, and emerging evidence in your research.

Biology
Development news
Analysis

Bring the full picture into focus.

See how Gosset can support your research on U6 small nuclear RNA 18 pseudogene (RNU6-18P).

Explore the full profile